The 2 most recent market catalysts affecting $BYSI, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 65
BeyondSpring Q2 EPS $(0.02) Up From $(0.04) YoY
BeyondSpring (BYSI) announced a significant reduction in its quarterly losses, with EPS improving from $(0.04) to $(0.02) year-over-year. This 50% improvement suggests that the com…
Aug 13, 2026
Corporate Catalyst
Bullish
Impact 75
BeyondSpring shares are trading higher after its subsidiary SEED Therapeutics secured FDA Orphan Drug Designation for Neuroblastoma candidate ST‑01156.
The FDA Orphan Drug Designation for ST-01156 is a significant positive catalyst for BeyondSpring. This designation grants special incentives, including tax credits, fee waivers, an…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.